Author:
Jufrizen Jufrizen,Al Fatin Illa Nurain
Abstract
The purpose of this study was to determine and analyze the influence of Debt to Equity Ratio, Return On Equity, Return On Assets and firm size on firm value either partially or simultaneously on Pharmaceutical Companies Listed on the Indonesia Stock Exchange. The approach used in this research is an associative approach. The population in this study are all pharmaceutical companies that are listed on the Indonesia Stock Exchange while the samples that meet the criteria for withdrawal of observations made for five years and as many as six (6) pharmaceutical companies listed on the Indonesia Stock Exchange. Data collection techniques in this study using documentation techniques. Data analysis techniques in this study used the Multiple Regression. The results of this study prove that partially there is no influence of Debt to Equity Ratio on firm value. there is no effect of Return On Equity on firm value, there is no effect of Return On Assets on firm value, there is no influence of firm value on firm value. Simultaneously there is no influence of Debt to Equity Ratio, Return On Equity, Return On Assets and firm size together on the firm value of pharmaceutical companies listed on the Indonesia Stock Exchange
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Dividend Policy's Role in Company Value: IDX Pharmaceutical Manufacturing (2013-2021);Indonesian Journal of Public Policy Review;2024-04-01
2. Profitability Drives Dividend Policy and Firm Value in the Digital Era;Proceedings of the International Conference on Intellectuals’ Global Responsibility (ICIGR 2022);2023